Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT03360721 · TERMINATED

Trial details

NCT number: NCT03360721
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Prostate Adenocarcinoma Without Neuroendocrine Differentiation Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8

Start date: 2018-03-06
Primary completion: 2026-03-12
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.